Dr. Michael Mauro on Treatment Discontinuation for CML Laura Martin 2:01 9 years ago 12 Далее Скачать
Dr. Michael Mauro on Toxicities of TKI Usage in CML Patients Targeted Oncology 1:07 9 years ago 389 Далее Скачать
New drugs for CML: are more to come? VJHemOnc – Video Journal of Hematology & HemOnc 0:38 6 years ago 199 Далее Скачать
Four Approved Frontline Treatments Benefit Patients with Chronic Myeloid Leukemia Targeted Oncology 0:52 5 years ago 217 Далее Скачать
Recommendations for treatment discontinuation in CML VJHemOnc – Video Journal of Hematology & HemOnc 2:18 2 years ago 401 Далее Скачать
The role of CML stem cells in relapse after TKI discontinuation & resistance to treatment VJHemOnc – Video Journal of Hematology & HemOnc 1:12 2 years ago 156 Далее Скачать
Treatments for Chronic Myeloid Leukemia can sometimes fail, but there is hope. WJHL 3:38 4 years ago 95 Далее Скачать
Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia Research To Practice 1:27:00 6 days ago 48 Далее Скачать
Managing cardiovascular risks associated with lifelong TKI therapy in CML VJHemOnc – Video Journal of Hematology & HemOnc 1:42 2 years ago 132 Далее Скачать
The importance of better selecting patients with CML who are eligible for treatment discontinuation VJHemOnc – Video Journal of Hematology & HemOnc 1:10 2 years ago 124 Далее Скачать
